Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Pancreatic Neoplasms 15Neoplasms 11Multiple Myeloma 9Colorectal Neoplasms 8Myelodysplastic Syndromes 7Leukemia, Myeloid, Acute 6Glioblastoma 5Sarcoma 4Prostatic Neoplasms 4Neoplasms, Plasma Cell 4Leukemia, Myelomonocytic, Chronic 4Carcinoma, Non-Small-Cell Lung 4Inflammation 3Breast Neoplasms 3Stomatitis 2Stomach Neoplasms 2Skin Neoplasms 2Primary Myelofibrosis 2Ovarian Neoplasms 2Neoplasms by Site 2Myofibroma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Liver Neoplasms 2Leukemia 2Glioma 2Frailty 2Digestive System Neoplasms 2Digestive System Diseases 2

Interventions

Cyclophosphamide 254fludarabine phosphate 165Cytarabine 160Methotrexate 128Busulfan 115Filgrastim 111fludarabine 102Peripheral Blood Stem Cell Transplantation 96Rituximab 94Antilymphocyte Serum 83Etoposide 81Cyclosporine 75Tacrolimus 74Mycophenolic Acid 73Whole-Body Irradiation 72Radiotherapy 70Melphalan 66Vincristine 55Dexamethasone 54Granulocyte Colony-Stimulating Factor 50Methylprednisolone 48Azacitidine 44Alemtuzumab 42Imatinib Mesylate 41Clofarabine 41sargramostim 40Idarubicin 36Daunorubicin 36Cord Blood Stem Cell Transplantation 36Mercaptopurine 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia × Ascorbic Acid × Clear all
NCT00274820 2020-07-27

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder

Case Comprehensive Cancer Center

Phase 2 Completed
15 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00671697 2013-06-04

Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia

Washington University School of Medicine

Phase 1 Completed
13 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡